Metabolomic analysis reveals an important role of sphingosine 1-phosphate in the development of HFMD due to EV-A71 infection
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01272-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Wangquan Ji und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Lysophospholipids, Sphingosine, Hand, Foot and Mouth Disease, Enterovirus A, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), China Postdoctoral Science Foundation (China Postdoctoral Foundation Project), Henan Province Science and Technology Research Project.
Abstract (Originalsprache)
Hand, foot, and mouth disease (HFMD) is a serious pediatric infectious disease that causes immeasurable physical and mental health burdens. Currently, there is a lack of information on the mechanisms of HFMD severity and early diagnosis. We performed metabolomic profiling of sera from 84 Enterovirus A71 (EV-A71) infections and 45 control individuals. Targeted metabolomics assays were employed to further validate some of the differential metabolic molecules. We identified significant molecular changes in the sera of HFMD patients compared to healthy controls (HCs). A total of 54, 60, 35, and 62 differential metabolites were screened between mild cases and HCs, severe cases and HCs, severe cases and mild cases, and among the three groups, respectively. These differential metabolites implicated dysregulation of the tricarboxylic acid cycle, alanine, aspartate, and glutamate metabolism, and valine, leucine, and isoleucine biosynthesis. The diagnostic panel based on some overlapped differential metabolites could effectively discriminate severe cases from mild cases with an AUC of 0.912 (95% CI: 0.85–0.97) using the logistic regression model. Next, we found the elevation of serum sphingosine 1-phosphate (S1P) level in EV-A71 infection mice, which was similar to clinical observation. Importantly, after blocking the release of S1P by MK571, the clinical symptoms and survival of mice were significantly improved, involving the reduction of leukocyte infiltration in infected brain tissues. Collectively, our data provided a landscape view of metabolic alterations in EV-A71 infected children and revealed regulating S1P metabolism was an exploitable therapeutic target against EV-A71 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
- Department of Infection Control, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- School of Public Health, Xinxiang Medical University, Xinxiang, Henan, China.
- Pingyuan Laboratory, Xinxiang, China.
ORCID-Profile: Wangquan Ji, Shuaiyin Chen, Haiyan Yang, Yuefei Jin
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
- Henan Province Science and Technology Research Project
- Open Research Fund of National Health Commission Key Laboratory of Birth Defects Prevention & Henan Key Laboratory of Population Defects Prevention
- Open Grant from the Pingyuan Laboratory
- Open Project of Henan Province Engineering Research Center of Diagnosis and Treatment of Pediatric Infection and Critical Care
Zitieren
APA
Ji, W., Dang, D., Zhou, G., Tao, L., Sun, T., Li, D., Cheng, C., Feng, H., Long, J., Chen, S., Yang, H., Duan, G., & Jin, Y. (2025). Metabolomic analysis reveals an important role of sphingosine 1-phosphate in the development of HFMD due to EV-A71 infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01272-24
Vancouver
Ji W, Dang D, Zhou G, Tao L, Sun T, Li D, et al. Metabolomic analysis reveals an important role of sphingosine 1-phosphate in the development of HFMD due to EV-A71 infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01272-24
BibTeX
@article{Ji2025,
author = {Ji, Wangquan and Dang, Dejian and Zhou, Guangyuan and Tao, Ling and Sun, Tiantian and Li, Dong and Cheng, Cheng and Feng, Huifen and Long, Jinzhao and Chen, Shuaiyin and Yang, Haiyan and Duan, Guangcai and Jin, Yuefei},
title = {Metabolomic analysis reveals an important role of sphingosine 1-phosphate in the development of HFMD due to EV-A71 infection},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01272-24}
}
EUVIMED